In vivo evaluation of [(18)F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography

Development of hypoxia-targeted therapies has stimulated the search for clinically applicable noninvasive markers of tumour hypoxia. Here, we describe the validation of [(18)F]fluoroetanidazole ([(18)F]FETA) as a tumour hypoxia marker by positron emission tomography (PET). Cellular transport and ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Barthel, H, Wilson, H, Collingridge, D R, Brown, G, Osman, S, Luthra, S K, Brady, F, Workman, P, Price, P M, Aboagye, E O
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409496/
https://www.ncbi.nlm.nih.gov/pubmed/15150578
http://dx.doi.org/10.1038/sj.bjc.6601862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409496/
https://www.ncbi.nlm.nih.gov/pubmed/15150578
http://dx.doi.org/10.1038/sj.bjc.6601862

Ejemplares similares